These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35328646)

  • 21. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.
    Rivoltini L; Chiodoni C; Squarcina P; Tortoreto M; Villa A; Vergani B; Bürdek M; Botti L; Arioli I; Cova A; Mauri G; Vergani E; Bianchi B; Della Mina P; Cantone L; Bollati V; Zaffaroni N; Gianni AM; Colombo MP; Huber V
    Clin Cancer Res; 2016 Jul; 22(14):3499-512. PubMed ID: 26944067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Extracellular Domain of Death Receptor 5 Inhibits TRAIL-Induced Apoptosis by Disrupting Receptor-Receptor Interactions.
    Vunnam N; Lo CH; Grant BD; Thomas DD; Sachs JN
    J Mol Biol; 2017 Sep; 429(19):2943-2953. PubMed ID: 28834692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm.
    Lonergan M; Aponso D; Marvin KW; Helliwell RJ; Sato TA; Mitchell MD; Chaiwaropongsa T; Romero R; Keelan JA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3835-44. PubMed ID: 12915677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.
    Zhou L; Wang W; Dicker DT; Humphreys RC; El-Deiry WS
    Cancer Biol Ther; 2011 Aug; 12(4):335-48. PubMed ID: 21785270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
    Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes.
    Sanlioglu AD; Griffith TS; Omer A; Dirice E; Sari R; Altunbas HA; Balci MK; Sanlioglu S
    J Cell Biochem; 2008 Jun; 104(3):710-20. PubMed ID: 18247339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
    Pal S; Shankar BS; Sainis KB
    Cytokine; 2013 Oct; 64(1):196-207. PubMed ID: 23972545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the human TRAIL gene.
    Allen JE; El-Deiry WS
    Cancer Biol Ther; 2012 Oct; 13(12):1143-51. PubMed ID: 22892844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.
    Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C
    J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival.
    Pritzker LB; Scatena M; Giachelli CM
    Mol Biol Cell; 2004 Jun; 15(6):2834-41. PubMed ID: 15064358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the TRAIL of obesity and diabetes.
    Harith HH; Morris MJ; Kavurma MM
    Trends Endocrinol Metab; 2013 Nov; 24(11):578-87. PubMed ID: 23948591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long and winding road to cancer treatment: the TRAIL system.
    Palacios C; Yerbes R; Sanchez-Perez T; Martin-Perez R; Cano-Gonzalez A; Lopez-Rivas A
    Curr Pharm Des; 2014; 20(17):2819-33. PubMed ID: 23944369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.
    Keuper M; Wernstedt Asterholm I; Scherer PE; Westhoff MA; Möller P; Debatin KM; Strauss G; Wabitsch M; Fischer-Posovszky P
    Cell Death Dis; 2013 Jan; 4(1):e474. PubMed ID: 23348588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.
    Di Bartolo BA; Chan J; Bennett MR; Cartland S; Bao S; Tuch BE; Kavurma MM
    Diabetologia; 2011 Dec; 54(12):3157-67. PubMed ID: 21965021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
    Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.